News

We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...
Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...
Whichever way the tariff winds blow (and I've no special knowledge of that), Novo Nordisk stock remains arguably the cheapest ...
Denmark's Novo Nordisk faces mounting pressure — from cheap copycats to US tariff threats — putting its weight-loss empire at ...
Diving into the complexities of sustainability within healthcare packaging that include circular economy strategies, takeback ...
Novo Nordisk (NYSE: NVO) and Cava Group (NYSE: CAVA) are excellent choices. Novo Nordisk's shares have significantly lagged ...
In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...
Russian drugmaker Geropharm has received a compulsory license from the Russian state to produce a generic of Ozempic ...
A 48-year-old from Suffolk County is one of over 30 people suing Ozempic's manufacturer for partial loss of vision.